Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma

NCT ID: NCT06292039

Last Updated: 2025-07-28

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 25 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2026-01-31
• Study Completion Date: 2026-06-30

Brief Summary

The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is:

• Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors?

Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

Conditions

Injury Traumatic; Survivorship; Trauma Injury

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Injury Thrivorship Pathway

Enrollment in the human-centered injury thrivorship pathway.

Group Type: EXPERIMENTAL

Human-Centered Injury Thrivorship Pathway

Intervention Type: OTHER

Enrollment in the human-centered injury thrivorship pathway.

Interventions

Human-Centered Injury Thrivorship Pathway

Enrollment in the human-centered injury thrivorship pathway.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient ≥ 18 years old presenting with a physical injury to Zuckerberg San Francisco General Hospital
• Admitted to the hospital ≥ 24 hours
• Discharged from the hospital alive
• San Francisco resident or unhoused in San Francisco
• Capacity for informed consent

Exclusion Criteria

• Patient < 18 years old
• Deceased during index hospitalization
• Unable to provide informed consent

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Center for Advancing Translational Sciences (NCATS)

NIH

Sponsor Role: collaborator

University of California, San Francisco

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Marissa A Boeck, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

Zuckerberg San Francisco General Hospital

San Francisco, California, United States

Countries

United States

Central Contacts

Marissa A Boeck, MD, MPH

Role: CONTACT

marissa.boeck@ucsf.edu

415-502-4745

Facility Contacts

Marissa A Boeck, MD, MPH

Role: primary

marissa.boeck@ucsf.edu

415-502-4745

References

Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7.

Reference Type: BACKGROUND

PMID: 20957426 (View on PubMed)

Other Identifiers

2KL2TR001870

Identifier Type: NIH

Identifier Source: secondary_id

View Link

P0555788

Identifier Type: -

Identifier Source: org_study_id